Till startsida
Till innehåll Läs mer om hur kakor används på gu.se

Psykosomatisk medicin


Jan Svedlund


Jan Svedlund
Phone: +46 (0)31 342 1275
Fax: +46 (0)31 82 98 35
E-mail: jan.svedlund@neuro.gu.se

The research group

Jan Svedlund, MD, PhD, Psychiatry, Head of Psychiatric Department
Aina Elander, Professor
Anders Bergstedt, MD, PhD student
Berndt Johansson, MD, PhD
Denada Kodra, MD, PhD student
Hans Bendz, MD, PhD, Psychiatry
Hans Strid, MD, PhD
Harald Aiff, MD, PhD student
Jonas Lundberg, MD, PhD
Lena Öhman, MD, PhD
Magnus Simrén, MD, Professor
Mattias Aurell, MD, Professor, Nephrology
Per-Ola Attman, Professor, Nephrology
Richard Arén, MD, PhD student
Staffan Schön, MD, PhD, Internal Medicine


Jan Svedlunds area of interest is psychosomatic medicine to promote and advance the scientific understanding of the interrelationships among biological, psychological, social and behavioral factors in human health and disease
His research group aims at increasing our knowledge of the relative importance of biological, psychological and social factors and how these factors interplay after breast reconstruction procedures following surgical treatment for breast cancer, lithium-induced end-stage renal disease and inflammatory bowel disease. The research team focuses on these issues in 3 different projects using psychiatric methods for clinical evaluation and psychological tests. Also we apply new psycho physiological measures in an interdisciplinary collaboration addressing the following psychosomatic research questions.

  • Which specific subjective symptoms are expressed by patients during the recovery period and which psychosocial factors determine quality of life after breast reconstruction procedures?
  • Has modern lithium treatment succeded in reducing or eliminating the risk of end-stage renal disease?
  • Are there psychosocial determinants of relapse in inflammatory bowel disease?
  • Do IBD-patients present abnormal auditory brain stem responses and can these characteristics be used for diagnostic purposes?

Findings from our studies may result in improved treatment options for the different patient populations. Better understanding of the ways in which psychosocial factors impact health, and development of new measures for clinical evaluation can be expected to improve the medical decision-making process and future intervention studies.


Sidansvarig: Josefin Bergenholtz|Sidan uppdaterades: 2012-08-17

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?